ロード中...
Predictive value and clinical utility of centrally-assessed ER, PgR and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
PURPOSE: The SOFT and TEXT randomized phase III trials investigated adjuvant endocrine therapies for premenopausal women with hormone receptor-positive (HR+) early breast cancer. We investigated the prognostic and predictive value of centrally-assessed levels of estrogen receptor (ER), progesterone...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749471/ https://ncbi.nlm.nih.gov/pubmed/26493064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3612-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|